VeriMomDevo evitar cannabigerol na gravidez? | VeriMom
No harmonised (Annex VI CLP) reproductive classification for cannabigerol (CBG) was identified; ECHA InfoCard shows company C&L notifications reporting H361d but this appears to come from C&L notifications rather than a legally harmonised CLH entry, and there are no CIR or SCCS safety opinions specific to CBG. Cannabinoids as a class (e.g., THC/CBD) have been associated with developmental effects in animal and human studies, giving a plausible class-based mechanism, but direct reproductive/teratogenic data for CBG are lacking; dermal absorption is plausible and likely low-but-measurable for a small lipophilic phytocannabinoid. (See ECHA InfoCard; PubChem; human/animal cannabinoid developmental reviews.).
ECHA regulatory hazard statements
- •H361D
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- cannabigerol é seguro durante a gravidez?
- No harmonised (Annex VI CLP) reproductive classification for cannabigerol (CBG) was identified; ECHA InfoCard shows company C&L notifications reporting H361d but this appears to come from C&L notifications rather than a legally harmonised CLH entry, and there are no CIR or SCCS safety opinions specific to CBG. Cannabinoids as a class (e.g., THC/CBD) have been associated with developmental effects in animal and human studies, giving a plausible class-based mechanism, but direct reproductive/teratogenic data for CBG are lacking; dermal absorption is plausible and likely low-but-measurable for a small lipophilic phytocannabinoid. (See ECHA InfoCard; PubChem; human/animal cannabinoid developmental reviews.).
- cannabigerol é seguro durante a amamentação?
- There are no authoritative safety assessments (CIR/SCCS/harmonised CLP) specifically identifying CBG as a confirmed reproductive or lactation hazard. Cannabinoids can be transferred to milk (class concern from THC/CBD literature) so a theoretical class-based mechanism exists, but direct studies on CBG transfer in human milk or lactation-specific toxicity are not found; topical cosmetic use would give low but measurable maternal systemic exposure in some scenarios, so breastfeeding exposure is possible but not characterized for CBG.
- cannabigerol é seguro para a pele do bebê?
- No infant-specific toxicity or safety data for topical CBG were identified. By class-based analogy to other cannabinoids there is a theoretical mechanism, but no direct evidence that CBG causes reproductive/infant toxicity. Because infant skin has higher absorption per kg, exposure score is increased by +1 compared with adults when measurable dermal absorption is plausible; direct dermal absorption studies for CBG were not found.
- Como o VeriMom pontua cannabigerol?
- O VeriMom pontua cannabigerol em 27/100 (risco alto) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.
- Quais são as alternativas seguras a cannabigerol na gravidez?
- Veja nossa lista curada de alternativas seguras a cannabigerol com base em função semelhante e classificação sem riscos conhecidos.
Verifique qualquer rótulo em 2 segundos
Baixe o VeriMom grátis — escaneie qualquer produto e veja a pontuação de segurança na gravidez instantaneamente.
Aviso Médico
Estas informações são apenas para fins educacionais e não constituem aconselhamento médico. As pontuações de segurança são baseadas em dados publicamente disponíveis e podem não refletir todos os riscos. Sempre consulte seu profissional de saúde antes de usar qualquer produto durante a gravidez ou amamentação.